HSV-1-Based Vectors for Gene Therapy of Neurological Diseases and Brain Tumors: Part II. Vector Systems and Applications
Open Access
- 1 November 1999
- Vol. 1 (5) , 402-416
- https://doi.org/10.1038/sj.neo.7900056
Abstract
No abstract availableKeywords
This publication has 197 references indexed in Scilit:
- A Novel Multiply-Mutated HSV-1 Strain for the Treatment of Human Brain TumorsHuman Gene Therapy, 1997
- Nerve growth factor somatic mosaicism produced by herpes virus-directed expression of ere recombinaseNature Biotechnology, 1997
- Long-Term Survival in a Rodent Model of Disseminated Brain Tumors by Combined Intrathecal Delivery of Herpes Vectors and Ganciclovir TreatmentHuman Gene Therapy, 1996
- Expression of bcl-2 From a Defective Herpes Simplex Virus–1 Vector Limits Neuronal Death in Focal Cerebral IschemiaStroke, 1995
- Effect of Exogenous Nerve Growth Factor on Neurotoxicity of and Neuronal Gene Delivery by a Herpes Simplex Amplicon Vector in the Rat BrainHuman Gene Therapy, 1994
- Mutant herpes simplex virus induced regression of tumors growing in immunocompetent ratsJournal of Neuro-Oncology, 1994
- GAL4 disrupts a repressing nucleosome during activation of GAL1 transcription in vivo.Genes & Development, 1993
- A latent, nonpathogenic HSV-1-derived vector stably expresses β-galactosidase in mouse neuronsNeuron, 1990
- GAL4-VP16 is an unusually potent transcriptional activatorNature, 1988
- Herpes Simplex Virus Genes Involved in Latency in vitroJournal of General Virology, 1987